- HealthVerity, headquartered in Philadelphia, Pennsylvania, specializes in real-world data technology and privacy-compliant data exchange, positioning itself as a leader in the healthcare data market.
- In January 2026, HealthVerity appointed Adam Greenfield as Chief Technology Officer to enhance its technology strategy, and in April 2026, it secured $25 million in Series C funding to further develop its healthcare data platform.
- The company recently formed a strategic partnership with Claritas Rx to provide actionable insights for commercial and real-world evidence generation, and it is also collaborating with ASTHO to launch a public health data consortium.
- HealthVerity's ideal buyers are pharmaceutical and healthcare organizations looking to improve data-driven decision-making and enhance patient outcomes, making it a critical partner for teams focused on real-world evidence and commercial visibility.
HealthVerity's workforce is organized into 12 departments, with a significant concentration in Information Technology, which employs 56 individuals. Engineering follows with a headcount of 15, while Operations and Sales contribute 13 and 11 employees, respectively. This distribution indicates a strong focus on technology and operational support, essential for the company's software development initiatives. The presence of smaller teams in Finance, Executive, and Legal departments further supports a balanced organizational structure.
The company's workforce is primarily based in Philadelphia, PA, with 51 employees, representing a significant geographic concentration. Other notable locations include New York, NY, with 6 employees, and Charlotte, NC, housing 4 staff members. The 'Other' category accounts for 43 employees across various locations, indicating a distributed workforce model. This geographic diversity allows HealthVerity to leverage talent from multiple regions while maintaining a strong operational hub in Philadelphia.
